CVS Group plc (LON:CVSG - Get Free Report) insider Richard Gray sold 305 shares of the business's stock in a transaction dated Wednesday, March 26th. The stock was sold at an average price of GBX 1,007 ($13.01), for a total value of £3,071.35 ($3,968.15).
CVS Group Trading Up 1.0 %
LON CVSG traded up GBX 10 ($0.13) during trading hours on Tuesday, hitting GBX 1,014 ($13.10). The company's stock had a trading volume of 134,280 shares, compared to its average volume of 326,665. The stock has a fifty day moving average of GBX 1,012.77 and a 200 day moving average of GBX 956.19. The company has a quick ratio of 0.90, a current ratio of 1.09 and a debt-to-equity ratio of 110.52. CVS Group plc has a twelve month low of GBX 791 ($10.22) and a twelve month high of GBX 1,226 ($15.84). The firm has a market capitalization of £726.76 million, a P/E ratio of 35.11, a PEG ratio of 1.77 and a beta of 1.02.
CVS Group (LON:CVSG - Get Free Report) last announced its quarterly earnings data on Thursday, February 27th. The company reported GBX 40 ($0.52) EPS for the quarter. CVS Group had a return on equity of 7.86% and a net margin of 3.20%. Equities research analysts forecast that CVS Group plc will post 93.9393939 earnings per share for the current fiscal year.
CVS Group Company Profile
(
Get Free Report)
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Featured Articles
Before you consider CVS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Group wasn't on the list.
While CVS Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.